| Citation: | Zhang LX,Hu DH.Research advances on the role of aerobic glycolysis in skin fibrosis diseases[J].Chin J Burns Wounds,2024,40(4):389-394.DOI: 10.3760/cma.j.cn501225-20230712-00004.
|
| [1] |
WynnTA, RamalingamTR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease[J]. Nat Med, 2012,18(7):1028-1040. DOI: 10.1038/nm.2807.
|
| [2] |
BairkdarM, RossidesM, WesterlindH, et al. Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis[J]. Rheumatology (Oxford), 2021,60(7):3121-3133. DOI: 10.1093/rheumatology/keab190.
|
| [3] |
FinnertyCC, JeschkeMG, BranskiLK, et al. Hypertrophic scarring: the greatest unmet challenge after burn injury[J]. Lancet, 2016,388(10052):1427-1436. DOI: 10.1016/S0140-6736(16)31406-4.
|
| [4] |
HuangC, WuZ, DuY, et al. The epidemiology of keloids[M/OL]//Téot L, Mustoe TA, Middelkoop E, et al. Textbook on scar management: state of the art management and emerging technologies. Cham(CH): Springer, 2020: 29-35[2023-05-18]. http://link.springer.com/ 10.1007/978-3-030-44766-3_4. DOI: 10.1007/978-3-030-44766-3_4.
|
| [5] |
HendersonNC, RiederF, WynnTA. Fibrosis: from mechanisms to medicines[J]. Nature, 2020,587(7835):555-566. DOI: 10.1038/s41586-020-2938-9.
|
| [6] |
PlikusMV, WangXJ, SinhaS, et al. Fibroblasts: origins, definitions, and functions in health and disease[J]. Cell, 2021,184(15):3852-3872. DOI: 10.1016/j.cell.2021.06.024.
|
| [7] |
RodriguesM, KosaricN, BonhamCA, et al. Wound healing: a cellular perspective[J]. Physiol Rev, 2019, 99(1): 665-706. DOI: 10.1152/physrev.00067.2017.
|
| [8] |
BianXL, JiangHF, MengY, et al. Regulation of gene expression by glycolytic and gluconeogenic enzymes[J]. Trends Cell Biol, 2022,32(9):786-799. DOI: 10.1016/j.tcb.2022.02.003.
|
| [9] |
WarburgO, WindF, NegeleinE. The metabolism of tumors in the body[J]. J Gen Physiol, 1927, 8(6): 519-530. DOI: 10.1085/jgp.8.6.519.
|
| [10] |
XieN, TanZ, BanerjeeS, et al. Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis[J]. Am J Respir Crit Care Med, 2015, 192(12): 1462-1474. DOI: 10.1164/rccm.201504-0780OC.
|
| [11] |
ChenZT, GaoQY, WuMX, et al. Glycolysis inhibition alleviates cardiac fibrosis after myocardial infarction by suppressing cardiac fibroblast activation[J]. Front Cardiovasc Med, 2021, 8: 701745. DOI: 10.3389/fcvm.2021.701745.
|
| [12] |
HuangT, LiYQX, ZhouMY, et al. Focal adhesion kinase-related non-kinase ameliorates liver fibrosis by inhibiting aerobic glycolysis via the FAK/Ras/c-myc/ENO1 pathway[J]. World J Gastroenterol, 2022,28(1):123-139. DOI: 10.3748/wjg.v28.i1.123.
|
| [13] |
ZhaoX, PsarianosP, GhoraieLS, et al. Metabolic regulation of dermal fibroblasts contributes to skin extracellular matrix homeostasis and fibrosis[J]. Nat Metab, 2019,1(1):147-157. DOI: 10.1038/s42255-018-0008-5.
|
| [14] |
OzawaT, OkamuraT, HaradaT, et al. Accumulation of glucose in keloids with FDG-PET[J]. Ann Nucl Med, 2006,20(1):41-44. DOI: 10.1007/BF02985589.
|
| [15] |
OkunoR, ItoY, EidN, et al. Upregulation of autophagy and glycolysis markers in keloid hypoxic-zone fibroblasts: morphological characteristics and implications[J]. Histol Histopathol, 2018,33(10):1075-1087. DOI: 10.14670/HH-18-005.
|
| [16] |
SitKH, LauYK, AwSE. Differential oxygen sensitivities in G6PDH activities of cultured keloid and normal skin dermis single cells[J]. J Dermatol, 1991,18(10):572-579. DOI: 10.1111/j.1346-8138.1991.tb03135.x.
|
| [17] |
苏治国,范金财,刘立强, 等. 瘢痕疙瘩成纤维细胞中Warburg效应的研究[J]. 中华整形外科杂志,2020,36(10):1100-1105. DOI: 10.3760/cma.j.cn114453-20200220-00064.
|
| [18] |
杨怡圆, 周仁鹏, 候家琳, 等. M2型丙酮酸激酶对瘢痕疙瘩成纤维细胞功能的影响[J].组织工程与重建外科杂志,2020,16(5):351-358. DOI: 10.3969/j.issn.1673-0364.2020.05.002.
|
| [19] |
HendersonJ, DuffyL, StrattonR, et al. Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis[J]. J Cell Mol Med, 2020,24(23):14026-14038. DOI: 10.1111/jcmm.16013.
|
| [20] |
AndreucciE, MargheriF, PeppicelliS, et al. Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis[J]. Rheumatology (Oxford), 2021,60(10):4508-4519. DOI: 10.1093/rheumatology/keab022.
|
| [21] |
VincentAS, PhanTT, MukhopadhyayA, et al. Human skin keloid fibroblasts display bioenergetics of cancer cells[J]. J Invest Dermatol, 2008,128(3):702-709. DOI: 10.1038/sj.jid.5701107.
|
| [22] |
ShenY, JiangL, WenP, et al. Tubule-derived lactate is required for fibroblast activation in acute kidney injury[J]. Am J Physiol Renal Physiol, 2020,318(3):F689-F701. DOI: 10.1152/ajprenal.00229.2019.
|
| [23] |
FrangogiannisN. Transforming growth factor-β in tissue fibrosis[J]. J Exp Med, 2020,217(3):e20190103. DOI: 10.1084/jem.20190103.
|
| [24] |
ShiML, ZhuJH, WangR, et al. Latent TGF-β structure and activation[J]. Nature, 2011,474(7351):343-349. DOI: 10.1038/nature10152.
|
| [25] |
KottmannRM, KulkarniAA, SmolnyckiKA, et al. Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β[J]. Am J Respir Crit Care Med, 2012,186(8):740-751. DOI: 10.1164/rccm.201201-0084OC.
|
| [26] |
LiuWH, WangY, BoziLHM, et al. Lactate regulates cell cycle by remodelling the anaphase promoting complex[J]. Nature, 2023, 616(7958): 790-797. DOI: 10.1038/s41586-023-05939-3.
|
| [27] |
IyerNV, KotchLE, AganiF, et al. Cellular and developmental control of O
2 homeostasis by hypoxia-inducible factor 1α[J]. Genes Dev, 1998, 12(2): 149-162. DOI: 10.1101/gad.12.2.149.
|
| [28] |
KimJW, TchernyshyovI, SemenzaGL, et al. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia[J]. Cell Metab, 2006,3(3):177-185. DOI: 10.1016/j.cmet.2006.02.002.
|
| [29] |
NagaoA, KobayashiM, KoyasuS, et al. HIF-1-dependent reprogramming of glucose metabolic pathway of cancer cells and its therapeutic significance[J]. Int J Mol Sci, 2019, 20(2): 238. DOI: 10.3390/ijms20020238.
|
| [30] |
WangQF, WangP, QinZL, et al. Altered glucose metabolism and cell function in keloid fibroblasts under hypoxia[J]. Redox Biol, 2021,38:101815. DOI: 10.1016/j.redox.2020.101815.
|
| [31] |
LiJY, YinYL, ZhangEY, et al. Peptide deregulated in hypertrophic scar-1 alleviates hypertrophic scar fibrosis by targeting focal adhesion kinase and pyruvate kinase M2 and remodeling the metabolic landscape[J]. Int J Biol Macromol, 2023,235:123809. DOI: 10.1016/j.ijbiomac.2023.123809.
|
| [32] |
AlquraishiM, PuckettDL, AlaniDS, et al. Pyruvate kinase M2: a simple molecule with complex functions[J]. Free Radic Biol Med, 2019,143:176-192. DOI: 10.1016/j.freeradbiomed.2019.08.007.
|
| [33] |
ZhengDD, JiangYC, QuC, et al. Pyruvate kinase M2 tetramerization protects against hepatic stellate cell activation and liver fibrosis[J]. Am J Pathol, 2020, 190(11): 2267-2281. DOI: 10.1016/j.ajpath.2020.08.002.
|
| [34] |
GaoJ, WeiT, HuangCL, et al. Sirtuin 3 governs autophagy-dependent glycolysis during Angiotensin Ⅱ-induced endothelial-to-mesenchymal transition[J]. FASEB J, 2020,34(12):16645-16661. DOI: 10.1096/fj.202001494R.
|
| [35] |
GaoSY, LiXH, JiangQY, et al. PKM2 promotes pulmonary fibrosis by stabilizing TGF-β
1receptor I and enhancing TGF-β
1 signaling[J]. Sci Adv, 2022,8(38):eabo0987. DOI: 10.1126/sciadv.abo0987.
|
| [36] |
VinaikR, BarayanD, AugerC, et al. Regulation of glycolysis and the Warburg effect in wound healing[J]. JCI Insight, 2020,5(17):e138949. DOI: 10.1172/jci.insight.138949.
|
| [37] |
ZhouMY, ChengML, HuangT, et al. Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells[J]. World J Gastroenterol, 2021,27(40):6908-6926. DOI: 10.3748/wjg.v27.i40.6908.
|
| [38] |
WangP, WangQF, YangX, et al. Targeting the glycolytic enzyme PGK1 to inhibit the Warburg effect: a new strategy for keloid therapy[J]. Plastic Reconstr Surg, 2023, 151(6): 970e-980e. DOI: 10.1097/PRS.0000000000010137.
|
| [39] |
MeiSY, XuQY, HuY, et al. Integrin β3-PKM2 pathway-mediated aerobic glycolysis contributes to mechanical ventilation-induced pulmonary fibrosis[J]. Theranostics, 2022,12(14):6057-6068. DOI: 10.7150/thno.72328.
|
| [40] |
LiQ, QinZL, NieFF, et al. Metabolic reprogramming in keloid fibroblasts: aerobic glycolysis and a novel therapeutic strategy[J]. Biochem Biophys Res Commun, 2018,496(2):641-647. DOI: 10.1016/j.bbrc.2018.01.068.
|
| [41] |
SchrufE, SchroederV, KuttruffCA, et al. Human lung fibroblast-to-myofibroblast transformation is not driven by an LDH5-dependent metabolic shift towards aerobic glycolysis[J]. Respir Res, 2019,20(1):87. DOI: 10.1186/s12931-019-1058-2.
|
| [42] |
WangFX, JiaY, LiMM, et al. Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells[J]. Cell Commun Signal, 2019,17(1):11. DOI: 10.1186/s12964-019-0324-8.
|
| [43] |
LiuYZ, BaiF, LiuN, et al. Metformin improves lipid metabolism and reverses the Warburg effect in a canine model of chronic atrial fibrillation[J]. BMC Cardiovasc Disord, 2020,20(1):50. DOI: 10.1186/s12872-020-01359-7.
|
| [44] |
TangCJ, XuJ, YeHY, et al. Metformin prevents PFKFB3-related aerobic glycolysis from enhancing collagen synthesis in lung fibroblasts by regulating AMPK/mTOR pathway[J]. Exp Ther Med, 2021,21(6):581. DOI: 10.3892/etm.2021.10013.
|
| [45] |
YuHL, ZhuJB, ChangLY, et al. 3-Bromopyruvate decreased kidney fibrosis and fibroblast activation by suppressing aerobic glycolysis in unilateral ureteral obstruction mice model[J]. Life Sci, 2021,272:119206. DOI: 10.1016/j.lfs.2021.119206.
|
| [46] |
WangW, ZhangY, HuangWH, et al. Alamandine/MrgD axis prevents TGF-β
1-mediated fibroblast activation via regulation of aerobic glycolysis and mitophagy[J]. J Transl Med, 2023,21(1):24. DOI: 10.1186/s12967-022-03837-2.
|
| [47] |
FanN, ZhangXY, ZhaoW, et al. Covalent inhibition of pyruvate kinase M2 reprograms metabolic and inflammatory pathways in hepatic macrophages against non-alcoholic fatty liver disease[J]. Int J Biol Sci, 2022, 18(14): 5260-5275. DOI: 10.7150/ijbs.73890.
|
| [1] | Heng Xue, Li Buying, Gao Shijie, Lu Changjin, Zhang Xiaorong, Hu Xiaohong, Luo Gaoxing, Li Haisheng. Role and mechanism of P311 in the differentiation of mouse skin fibroblasts into myofibroblasts[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2024, 40(9): 849-856. doi: 10.3760/cma.j.cn501225-20231215-00245 |
| [2] | Chen Wei, Xu Guangchao, Huang Zhonglu, Chen Li, Nie Kaiyu. Research advances on the mechanism of nerve regeneration-related protein in skin fibrosis[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2023, 39(5): 491-495. doi: 10.3760/cma.j.cn501225-20220701-00278 |
| [3] | Wang Chang, Chen Wei, Wang Baojia. Regulatory effects and signaling mechanism of sodium ferulate on the proliferation and apoptosis of human skin hypertrophic scar fibroblasts[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2022, 38(5): 471-480. doi: 10.3760/cma.j.cn501120-20201120-00484 |
| [4] | Yu Xiaoping, Liu Yingkai, Ma Xian, Tang Jiajun, Niu Yiwen, Zhou Junli, Lu Shuliang. Effect of deep dermal tissue dislocation injury on skin fibrosis in pig[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2022, 38(11): 1057-1065. doi: 10.3760/cma.j.cn501120-20210831-00301 |
| [5] | Guo Bingyu, Lin Feng, Bai Zeming, Tao Kai, Wang Hongyi. Expression of microRNA-296 in rabbit hypertrophic scars and its role to human fibroblasts[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2021, 37(8): 725-730. doi: 10.3760/cma.j.cn501120-20210420-00142 |
| [6] | Zhu Dongzhen, Yao Bin, Cui Xiaoli, Huang Sha, Fu Xiaobing. Effects and mechanism of age on the stiffness and the fibrotic phenotype of fibroblasts of human hypertrophic scar[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2021, 37(10): 937-945. doi: 10.3760/cma.j.cn501120-20200810-00374 |
| [7] | He Xiang, Li Jie, Liu Jiaqi, Zheng Zhao, Hu Dahai. Expressions and effects of autophagy-related genes in bleomycin-induced skin fibrosis of mice[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2020, 36(5): 346-356. doi: 10.3760/cma.j.cn501120-20200210-00047 |
| [8] | Wang Zhiyong, Wang Xiqiao, Liu Yingkai, Yuan Bo, Dong Jiaoyun, Song Fei, Jiang Yuzhi, Lu Shuliang. Effects of denatured collagen type Ⅰ on differentiation of human fibroblasts into myofibroblasts[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2018, 34(2): 96-101. doi: 10.3760/cma.j.issn.1009-2587.2018.02.007 |
| [9] | Kuang Fang, Zhang Zhi, Chen Bin, Liu Changling, Zhao Yuanyuan, Xu Zhirong, Li Xiaojian. The expression of SnoN in human hypertrophic scar fibroblasts and the mechanism of its participation in hypertrophic scar formation[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2017, 33(10): 634-638. doi: 10.3760/cma.j.issn.1009-2587.2017.10.011 |
| [10] | Zhang Zhi, Kuang Fang, Liu Changling, Chen Bin, Tang Wenbin, Li Xiaojian. Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2017, 33(3): 145-151. doi: 10.3760/cma.j.issn.1009-2587.2017.03.004 |
| [11] | Ren Haitao, Li Yuan, Wang Shengdong, Han Chunmao. Effects of endostatin pretreatment on fibrosis of human skin fibroblasts and the mechanisms[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2017, 33(11): 694-698. doi: 10.3760/cma.j.issn.1009-2587.2017.11.007 |
| [12] | Zhang Lu, Li Haisheng, Yao Zhihui, Yang Sisi, He Weifeng, Wu Jun, Luo Gaoxing. Interaction between P311 and transforming growth factor beta 1 and its effect on the function of murine fibroblasts[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2016, 32(4): 208-215. doi: 10.3760/cma.j.issn.1009-2587.2016.04.005 |
| [13] | Wang Yang, Zhang Liangping, Lei Rui, Shen Yichen, Shen Hui, Wu Zhinan, Xu Jinghong. Effects of blocking two sites of transforming growth factor-β/Smads signaling on the formation of scar-related proteins in human skin fibroblasts[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2015, 31(5): 372-377. doi: 10.3760/cma.j.issn.1009-2587.2015.05.013 |
| [14] | Yu Xiaoping, Kang Yutian, Zuo Yanhai, Liu Chuanbo, Ye Junna, Yuan Bo, Ji Xiaoyun, Song Fei, Jiang Yuzhi, Xiao Yurui, Jin Shuwen, Lu Shuliang. Fibrosis after damage to fat dome structure of skin of pig[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2015, 31(5): 349-353. doi: 10.3760/cma.j.issn.1009-2587.2015.05.009 |
| [16] | LIU Da-en, LI Xuan, ZHANG Guo-you, NIU Zhan-guo, YI Cheng-gang, JIA Yu-bo, XIA Wei, GUO Shu-zhong. Experimental study on effect of hirudin in inhibiting hyperplastic scar fibroblasts[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2009, 25(4): 265-267. |
| [17] | TENG Miao, HUANG Yue-sheng, DANG Yong-ming, FANG Ya-dong, ZHANG Qiong. The influence of microtubule intervention drugs on glycolytic key enzymes in myocardial cells after hypoxia[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2008, 24(2): 102-106. |
| [18] | YANG Ping, WANG Ai-li, LIU De-wu, XU Shun, GU Yao-hui, HUANG Jing, CHEN Bo, LUO Qian-cheng, JIA Qing, WU Zhi-hong. Effect of transfection of recombinant human endothelial nitric oxide synthase gene on hypertrophic scar fibroblasts in vitro[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2008, 24(4): 275-277. |
| [19] | ZHANG Zhi, LI Xiao-jian, LIANG Da-rong, LI Ye-yang, XU Wei-shi. The antagonistic effect of recombinant human decorin on TGF-β1 stimulation of fibroblasts in collagen lattices of scar[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2006, 22(3): 207-210. |
| [20] | ZHANG Cheng-de, ZHANG Cai-ping, SONG Lan, LONG Shi-yin, TIAN Ying. An experimental study on the role of protein kinase C in the down-regulation of fibroblast proliferation in normal skin and hyperplastic scar by adrenaline[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2005, 21(6): 448-451. |
Figures(1)
Copyright © Chinese Journal of Burns京ICP备07035254号-14
E-mail：shaoshangzazhi@163.com
Supported by:
Beijing Renhe Information Technology Co. Ltd
Zhang LX,Hu DH.Research advances on the role of aerobic glycolysis in skin fibrosis diseases[J].Chin J Burns Wounds,2024,40(4):389-394.DOI: 10.3760/cma.j.cn501225-20230712-00004.
DownLoad: